
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5095175
[patent_doc_number] => 20070116784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Imatinib combinations for head and neck cancers'
[patent_app_type] => utility
[patent_app_number] => 10/557330
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5338
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116784.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557330
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557330 | Imatinib combinations for head and neck cancers | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7330208
[patent_doc_number] => 20040254229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Use of glucose uptake enhancer for reducing apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/797841
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5094
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797841 | Use of glucose uptake enhancer for reducing apoptosis | Mar 9, 2004 | Abandoned |
Array
(
[id] => 4445157
[patent_doc_number] => 07863322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Anti-cancer combinations'
[patent_app_type] => utility
[patent_app_number] => 10/790943
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10347
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790943
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790943 | Anti-cancer combinations | Mar 1, 2004 | Issued |
Array
(
[id] => 121877
[patent_doc_number] => 07709525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Chroman-derived anti-androgens for treatment of androgen-mediated disorders'
[patent_app_type] => utility
[patent_app_number] => 10/789835
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14629
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789835 | Chroman-derived anti-androgens for treatment of androgen-mediated disorders | Feb 26, 2004 | Issued |
Array
(
[id] => 7316653
[patent_doc_number] => 20040223926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Coating solution for forming wettability-varied pattern and method of producing pattern-formed body'
[patent_app_type] => new
[patent_app_number] => 10/786790
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15317
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786790 | Coating solution for forming wettability-varied pattern and method of producing pattern-formed body | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7151341
[patent_doc_number] => 20040171678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Method of treating cancer using dithiocarbamate derivatives'
[patent_app_type] => new
[patent_app_number] => 10/787030
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15995
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787030 | Method of treating cancer using dithiocarbamate derivatives | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7468891
[patent_doc_number] => 20040167170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Methods of preventing breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/785326
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6574
[patent_no_of_claims] => 144
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785326 | Methods of preventing breast cancer | Feb 23, 2004 | Abandoned |
Array
(
[id] => 7469007
[patent_doc_number] => 20040167180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Methods for anti-tumor therapy'
[patent_app_type] => new
[patent_app_number] => 10/784413
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6647
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10784413
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/784413 | Methods for anti-tumor therapy | Feb 22, 2004 | Abandoned |
Array
(
[id] => 7051305
[patent_doc_number] => 20050187192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses'
[patent_app_type] => utility
[patent_app_number] => 10/783927
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24697
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783927 | Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses | Feb 19, 2004 | Abandoned |
Array
(
[id] => 7051304
[patent_doc_number] => 20050187191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Methods and compositions for the treatment of respiratory syncytial virus'
[patent_app_type] => utility
[patent_app_number] => 10/781894
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18750
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781894 | Methods and compositions for the treatment of respiratory syncytial virus | Feb 19, 2004 | Abandoned |
Array
(
[id] => 7306409
[patent_doc_number] => 20040116490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Compounds and methods'
[patent_app_type] => new
[patent_app_number] => 10/473103
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9762
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473103 | Compounds and methods | Feb 19, 2004 | Abandoned |
Array
(
[id] => 7346777
[patent_doc_number] => 20040192639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Dramatic simplification of a method to treat neoplastic disease by radiation'
[patent_app_type] => new
[patent_app_number] => 10/779746
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12755
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779746 | Dramatic simplification of a method to treat neoplastic disease by radiation | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7469275
[patent_doc_number] => 20040167205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/782521
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7501
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782521 | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7275172
[patent_doc_number] => 20040234623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities'
[patent_app_type] => new
[patent_app_number] => 10/780797
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20539
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780797 | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities | Feb 16, 2004 | Issued |
Array
(
[id] => 7433663
[patent_doc_number] => 20040162353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate'
[patent_app_type] => new
[patent_app_number] => 10/780921
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13035
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780921 | Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7432438
[patent_doc_number] => 20040162264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Methods, pharmaceutical and therapeutic compositions for administering adenosine'
[patent_app_type] => new
[patent_app_number] => 10/777043
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4922
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777043 | Methods, pharmaceutical and therapeutic compositions for administering adenosine | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7436817
[patent_doc_number] => 20040185117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Cephalotaxine alkaloid compositions and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/769638
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4213
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769638 | Cephalotaxine alkaloid compositions and uses thereof | Jan 29, 2004 | Abandoned |
Array
(
[id] => 7678065
[patent_doc_number] => 20040151761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Methods and compositions utilizing astaxanthin'
[patent_app_type] => new
[patent_app_number] => 10/764215
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7341
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151761.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764215 | Methods and compositions utilizing astaxanthin | Jan 22, 2004 | Abandoned |
| 10/764177 | Dynamic variable release technology | Jan 22, 2004 | Abandoned |
Array
(
[id] => 7405541
[patent_doc_number] => 20040175767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Methods and compositions that affect melanogenesis'
[patent_app_type] => new
[patent_app_number] => 10/758335
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36845
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758335 | Methods and compositions that affect melanogenesis | Jan 14, 2004 | Abandoned |